These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 5841182)
1. Cardiotonic and active transport-inhibiting action of some cardiotonic glycosides and ivorine. Erjavec F; Adamic S Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):251-61. PubMed ID: 5841182 [No Abstract] [Full Text] [Related]
2. [A study of the toxic and therapeutic effect of cardiac glycosides during their long-term and combined use]. Demek L; Sporni L Kardiologiia; 1969 Jul; 9(7):57-63. PubMed ID: 5373726 [No Abstract] [Full Text] [Related]
3. [Inhibition of potassium and sodium transport in erythrocytes by glycosides containing a saturated lactone ring]. Reiter M; Weber S Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(2):131-9. PubMed ID: 4245721 [No Abstract] [Full Text] [Related]
4. [Basis of the active mechanism of cardioactive glycoside]. Schoner W Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():6-18. PubMed ID: 148185 [No Abstract] [Full Text] [Related]
5. Proceedings: Influence of potassium deficiency and chronic treatment with digitoxin on the activity of the (Na+ plus K+)-activated ATPase and digitoxin toxicity. Bluschke V; Bonn R; Greeff K Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R9. PubMed ID: 4276522 [No Abstract] [Full Text] [Related]
6. Inhibition of sodium transport in frog skin by cardiac glycosides of different molecular structure. Natochin YV; Lavrova EA Experientia; 1972 Aug; 28(8):942-3. PubMed ID: 4538603 [No Abstract] [Full Text] [Related]
7. [Pharmacological properties of acetyldigoxin-alpha]. Grauwiler J; Schalch WR; Taeschler M Schweiz Med Wochenschr; 1966 Oct; 96(41):1381-8. PubMed ID: 5972714 [No Abstract] [Full Text] [Related]
8. [New aspects in the mechanism of action of cardiac glycosides]. Böhm A Cesk Pediatr; 1973 Jan; 28(1):35-8. PubMed ID: 4734380 [No Abstract] [Full Text] [Related]
9. [Studies on the question of "real" effect value of cardiotonic steroids--determination of molar optimal titer in cats]. Vogel G; Baumann I Arzneimittelforschung; 1969 Apr; 19(4):657-9. PubMed ID: 5819169 [No Abstract] [Full Text] [Related]
10. [Certain problems of pharmacodynamics, pharmacokinetics and the use of cardiac glycosides]. Kukes VG; Volkov RIu Kardiologiia; 1977 Sep; 17(9):135-42. PubMed ID: 144820 [No Abstract] [Full Text] [Related]
11. [Difficulties in the biological evaluation of digitalis extracts]. Schaumann W; Kaiser F Arzneimittelforschung; 1967 Oct; 17(10):1264-6. PubMed ID: 5632874 [No Abstract] [Full Text] [Related]
12. Active transport of sodium and potassium ions: mechanism, function, and regulation. Sweadner KJ; Goldin SM N Engl J Med; 1980 Apr; 302(14):777-83. PubMed ID: 6243739 [No Abstract] [Full Text] [Related]
13. [Quantitative comparison of the positively inotropic and of the toxic effect of several cardiac glycosides]. Klupp H Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966 Jan; 252(4):314-31. PubMed ID: 4222840 [No Abstract] [Full Text] [Related]
14. Digitalis toxicity and hypomagnesemia. Seller RH; Cangiano J; Kim KE; Mendelssohn S; Brest AN; Swartz C Am Heart J; 1970 Jan; 79(1):57-68. PubMed ID: 5410283 [No Abstract] [Full Text] [Related]
15. [The potency, onset of action, detoxication and absorption from gastrointestinal tract of the several kinds of digitalis]. Furukawa T Nihon Yakurigaku Zasshi; 1965 Jul; 61(4):231-7. PubMed ID: 5894333 [No Abstract] [Full Text] [Related]
16. [Determination of the plasma protein binding of cardiac glycosides by measuring the Na plus-K+ transport in erythrocytes]. Kobinger W; Wenzel B Wien Klin Wochenschr; 1970 Mar; 82(11):195-9. PubMed ID: 5535107 [No Abstract] [Full Text] [Related]